Key Details of the GLP-1 Bridge Program Timeline Start date: July 1, 2026 End date: December 31, 2027 Transition: The BALANCE Model launches January 1, 2027 and will run alongside the Bridge through 2027 Which Drugs Are Covered
In: Erdman JW Jr., Macdonald IA, Zeisel SH
Burton BK, Deegan PB, Enns GM, Guardamagna O, Horslen S, Hovingh GK, Lobritto SJ, Malinova V, McLin VA, Raiman J, Di Rocco M, Santra S, Sharma R, Sykut-Cegielska J, Whitley CB, Eckert S, Valayannopoulos V, Quinn AG
The relationship between tirzepatide and migraines is not a set-it-and-forget-it situation
She kept gaining
A study published in Pharmaceutical Research found impurities and impurity patterns in compounded injectable semaglutide products, including trace metals and residual solvents